State Medicaid Policies on Antiobesity Medications Explored
The rising obesity epidemic poses significant challenges to public health, driving researchers and healthcare policymakers to seek effective interventions. A ...
The rising obesity epidemic poses significant challenges to public health, driving researchers and healthcare policymakers to seek effective interventions. A ...
About The Study: In this cohort study, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with reduced risk of developing nonexudative ...
A commonly prescribed medication for type 2 diabetes and obesity, semaglutide, is showing remarkable promise as a potential therapeutic agent ...
In the realm of neonatal medicine, bronchopulmonary dysplasia (BPD) continues to pose a significant clinical challenge, particularly in premature infants ...
The landscape of diabetes treatment is continually evolving, with an increased emphasis on medication options that are not only effective ...
A recent cohort study published in JAMA Ophthalmology has unveiled a potentially alarming association between the use of glucagon-like peptide-1 ...
In a groundbreaking development at the intersection of psychiatry, neurodevelopment, and pharmacogenetics, recent research has unveiled the potential of glucagon-like ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine